Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

    Mazyar Shadman, Joachim Deeg
    e2014056
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.056
    2185
    PDF: 819
    HTML: 3266
  • EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

    Eduardo Magalhães Rego, Rafael Henriques Jácomo
    e2011049
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.049
    2802
    PDF: 1114
    HTML: 2582
  • IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis

    Derya Alabaz, Fadime Eroğlu, Hüseyin Elçi, Ümmühan Çay
    e2022053
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.053
    1121
    PDF: 758
    HTML: 280
  • Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

    Bhavya S Doshi, Valder R Arruda, Valder R Arruda
    e2020069
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.069
    2264
    PDF: 2001
    HTML: 527
  • NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

    Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi
    e2019002
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.002
    7124
    PDF: 3782
    HTML: 829
  • OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY

    Mohamed Amine BEKADJA
    e2017062
    2017-10-25
    https://doi.org/10.4084/mjhid.2017.062
    2988
    PDF: 769
    HTML: 927
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2473
    PDF: 1925
    HTML: 179
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1211
    PDF: 932
    HTML: 305
  • IRON DEFICIENCY ANEMIA IN CHILDREN RESIDING IN HIGH AND LOW-INCOME COUNTRIES: RISK FACTORS, PREVENTION, DIAGNOSIS AND THERAPY

    ELPIS MANTADAKIS
    e2020041
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.041
    10308
    PDF: 6465
    HTML: 780
  • MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

    Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan
    e2015001
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.001
    2405
    PDF: 1374
    HTML: 17211
    Bassan Fig.1: 170
    Bassan Fig.2: 277
    Bassan Fig.4: 163
    Fig.3: 240
  • IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

    Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
    e2019063
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.063
    1542
    PDF: 799
    HTML: 263
  • HOW I TREAT FEBRILE NEUTROPENIA

    Marcio Nucci
    e2021025
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.025
    7204
    PDF: 4086
    HTML: 675
  • DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

    Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà
    e2018040
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.040
    3922
    PDF: 1361
    HTML: 925
    Figure 2: 496
    Figure 1: 3178
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    1699
    PDF: 1942
    Suppl. Files: 241
    HTML: 111
  • SHORT TERM ADVANTAGES OF A PUBLIC-PRIVATE PARTNERSHIP FOR TUBERCULOSIS IN GUINEA BISSAU: REDUCTION OF MORTALITY AND INCREASED DIAGNOSTIC CAPACITY

    Fina Vieira, Mamadu Saliu Sanha, Fabio Riccardi, Raffaella Colombatti
    e2014049
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.049
    1484
    PDF: 965
    HTML: 1311
    Untitled: 210
  • Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome

    alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine
    e2024030
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.030
    700
    PDF: 1082
    HTML: 105
  • EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever

    Cumali Yalçın, Fahir Özkalemkaş, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Merve Nur Akyol, Nevriye Gül Ada, Cüneyt Özakın, Esra Kazak, Halis Akalın, Rıdvan Ali
    e2022039
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.039
    1635
    PDF: 1162
    HTML: 267
  • ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

    Vincenzo De Sanctis
    e2016001
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.001
    5615
    PDF: 1360
    HTML: 3666
  • THALASSAEMIA INTERMEDIA : AN UPDATE

    Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini
    e2009004
    2009-08-17
    1122
    PDF: 469
    HTML: 9474
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4322
    PDF: 1277
    HTML: 1417
  • DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura

    Yi Liu, Fan Lu, Binbin Ji, Wei Song, Hui Shen, Yingjie Xu, bining Yang
    e2026019
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.019
    897
    PDF: 767
    HTML: 239
  • THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.

    Ugo Testa, Giuseppe Leone, Prof. M.D. Cappellini
    e2024068
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.068
    2327
    PDF: 1390
    Html: 379
  • ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS

    Junyue Cao, YuChao Sun
    e2025060
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.060
    1030
    PDF: 612
    Html: 311
    Suppl. Files: 198
  • CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

    Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri
    e2024038
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.038
    2661
    PDF: 1258
    HTML: 129
  • LUMBAR PUNCTURE: A CROSS-SECTIONAL STUDY USING THE CHINESE VERSION OF THE STATE ANXIETY SCALE FOR CHILDREN.

    Xiuli Qin, Xin Zhao, Ting Zhou, Danyan Yang, Genzhen Yu
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.021
    736
    PDF: 567
    HTML: 153
  • ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE

    Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti
    e2014030
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.030
    2069
    PDF: 1341
    HTML: 6513
  • A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA

    Michele Baccarani, Fabrizio Pane
    e2014010
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.010
    3331
    PDF: 1409
    HTML: 4158
  • CLINICAL AND LABORATORY CHARACTERISTICS OF DENGUE-ORIENTI TSUTSUGAMUSHI CO-INFECTION FROM A TERTIARY CARE CENTER IN SOUTH INDIA

    Aneesh Basheer, Nayyar Iqbal, Sudhagar Mookkappan, Patricia Anitha, Shashikala Nair, Reba Kanungo, Ravichandran Kandasamy
    e2016028
    2016-06-16
    https://doi.org/10.4084/mjhid.2016.028
    5155
    PDF: 963
    HTML: 1606
  • HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

    Michele Bibas, Gianluigi Biava, Andrea Antinori
    e2011030
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.030
    4612
    PDF: 1541
    HTML: 8542
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2629
    PDF: 1774
    HTML: 635
  • CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

    Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda
    e2019067
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.067
    3106
    PDF: 1913
    HTML: 911
  • T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections

    Muhamad R. Abdel Hameed, Sherein G. Elgendy, Mohamed A El-Mokhtar, Douaa Sayed, Samar M. Mansour, Abeer M. Darwish
    e2022022
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.022
    1911
    PDF: 785
    HTML: 506
  • Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

    Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.029
    500
    PDF: 452
    HTML: 112
  • PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.

    Dilip Kumar Patel, Manoj Kumar Mohapatra, Ancil George Thomas, Siris Patel, Prasanta Purohit
    e2014018
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.018
    2155
    PDF: 1102
    HTML: 15737
    COVER LETTER: 226
  • INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

    Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley
    e2013023
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.023
    2083
    PDF: 796
    HTML: 725
    Table1: patient's characteristics: 190
    Table 2: profile of each patient: 211
  • BETA THALASSEMIA MAJOR IN A DEVELOPING COUNTRY: EPIDEMIOLOGICAL, CLINICAL AND EVOLUTIONARY ASPECT

    Mohamed Bejaoui, Naouel Guirat
    e2013002
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.002
    1728
    PDF: 938
    HTML: 2537
  • INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA

    Sutatta Supatharawanich, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Bunchoo Pongtanakul, Sasima Tongsai, Phakatip Sinlapamongkolkul, Popchai Ngamskulrungroj, Wanatpreeya Phongsamart, Kleebsabai Sanpakit , Jassada Buaboonnam
    e2021039
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.039
    2908
    PDF: 968
    HTML: 305
  • Sickle Cell Disease: Management options and challenges in developing countries

    Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong
    e2013062
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.062
    3024
    PDF: 1349
    HTML: 1058
  • CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY

    Lodovico Balducci
    e2014037
    2014-05-31
    https://doi.org/10.4084/mjhid.2014.037
    2974
    PDF: 1172
    HTML: 3080
  • IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti
    e2016057
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.057
    4516
    PDF: 1184
    HTML: 1448
  • PLATELET COUNT RESPONSE TO HELICOBACTER PYLORI ERADICATION IN IRANIAN ?PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC ?PURPURA

    Mohammad Erfan Zare
    e2012056
    2012-08-10
    https://doi.org/10.4084/mjhid.2012.056
    2043
    PDF: 864
    HTML: 1512
51 - 91 of 91 items << < 1 2 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.